Literature DB >> 2373681

Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant Chinese hamster ovary cells.

M Takeuchi1, S Takasaki, M Shimada, A Kobata.   

Abstract

Human erythropoietin contains three Asn-type and one mucin-type sugar chains. That the branching structure of the outer portion of Asn-type sugar chains is correlated to its biological activity in vivo has been reported recently (Takeuchi, M., Inoue, N., Strickland, T. W., Kubota, M., Wada, M., Shimizu, R., Hoshi, S., Kozutsumi, H., Takasaki, S., and Kobata, A. (1989) Proc. Natl. Acad. Sci. U. S. A. 86, 7819-7822). In this study, the effect of trimming of sugar chains on the biological activity in vitro of this hormone was examined by using several glycosidases. Human erythropoietin produced by recombinant Chinese hamster ovary cells showed three times higher activity after desialylation. The activity was not changed significantly by further removal of the mucin-type sugar chain from the hormone, indicating no contribution of this type of sugar chain to the activity of erythropoietin in vitro. Sequential removal of galactose and N-acetylglucosamine from the outer chain moieties of the desialylated Asn-type sugar chains raised the activity of the hormone up to four and five times the intact erythropoietin, respectively. The activation effect was diminished slightly by further removing alpha-mannosyl residues and to a great extent by removing beta-mannosyl residues from the core portions of the Asn-type sugar chains. N-Glycanase digestion of intact erythropoietin resulted in almost complete loss of the activity in vitro. These results indicate that the core portion of the Asn-type sugar chains is necessary for erythropoietin to express its full biological activity in vitro and suggest that removal of the core portion of the sugar chains destroys the active conformation of erythropoietin.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2373681

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Study on the quality of recombinant proteins using matrix-assisted laser desorption ionization time of flight mass spectrometry.

Authors:  Guo-Hua Zhou; Guo-An Luo; Ya-Cheng Cao; Ming-Sheng Zhu
Journal:  World J Gastroenterol       Date:  1999-06       Impact factor: 5.742

2.  Genetic engineering of α2,6-sialyltransferase in recombinant CHO cells and its effects on the sialylation of recombinant interferon-γ.

Authors:  L Monaco; A Marc; A Eon-Duval; G Acerbis; G Distefano; D Lamotte; J M Engasser; M Soria; N Jenkins
Journal:  Cytotechnology       Date:  1996-01       Impact factor: 2.058

3.  Solid phase synthesis of the fibronectin glycopeptide V(Gal beta 3GalNAc alpha)THPGY, its beta analogue, and the corresponding unglycosylated peptide.

Authors:  B Lüning; T Norberg; C Rivera-Baeza; J Tejbrant
Journal:  Glycoconj J       Date:  1991-12       Impact factor: 2.916

4.  Cloning and expression of a porcine UDP-GalNAc: polypeptide N-acetylgalactosaminyl transferase.

Authors:  A Yoshida; T Hara; H Ikenaga; M Takeuchi
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

5.  Preparation of antisera to recombinant, soluble N-acetylglucosaminyltransferase V and its visualization in situ.

Authors:  L Chen; N Zhang; B Adler; J Browne; N Freigen; M Pierce
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

6.  At last: erythropoietin as a single glycoform.

Authors:  Ping Wang; Suwei Dong; John A Brailsford; Karthik Iyer; Steven D Townsend; Qiang Zhang; Ronald C Hendrickson; JaeHung Shieh; Malcolm A S Moore; Samuel J Danishefsky
Journal:  Angew Chem Int Ed Engl       Date:  2012-09-25       Impact factor: 15.336

7.  Molecular Design, Expression and Evaluation of PASylated Human Recombinant Erythropoietin with Enhanced Functional Properties.

Authors:  Mohammad Hossein Hedayati; Dariush Norouzian; Mahdi Aminian; Shahram Teimourian; Reza Ahangari Cohan; Soroush Sardari; M Reza Khorramizadeh
Journal:  Protein J       Date:  2017-02       Impact factor: 2.371

Review 8.  Differentiating factors between erythropoiesis-stimulating agents: a guide to selection for anaemia of chronic kidney disease.

Authors:  Robert Deicher; Walter H Hörl
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Structural analysis and localization of the carbohydrate moieties of a soluble human interferon gamma receptor produced in baculovirus-infected insect cells.

Authors:  M Manneberg; A Friedlein; H Kurth; H W Lahm; M Fountoulakis
Journal:  Protein Sci       Date:  1994-01       Impact factor: 6.725

Review 10.  Carbohydrate analysis throughout the development of a protein therapeutic.

Authors:  Elizabeth Higgins
Journal:  Glycoconj J       Date:  2009-11-04       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.